Serum level of interleukin 8 is elevated in idiopathic pulmonary fibrosis and indicates disease activity

American Journal of Respiratory and Critical Care Medicine

Volumn 157, Issue 3 PART I, 1998, Pages 762-768

  Ziegenhagen, Manfred W ^a   Zabel, Peter ^a   Zissel, Gernot ^a   Schlaak, Max ^a   Müller Quernheim, Joachim ^a  

^a Medical Hospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 8;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; HUMAN; LUNG ALVEOLITIS; LUNG FIBROSIS; LUNG FUNCTION; MALE; PRIORITY JOURNAL; SERODIAGNOSIS;

EID: 0031921467     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.157.3.9705014     Document Type: Article

References (30)

1. Haslam, P. L., C. W. G. Turton, B. Heard, and M. Turner-Warwick. 1980. Bronchoalveolar lavage in pulmonary fibrosis: comparison of cells obtained with lung biopsy and clinical features. Thorax 35:9-18.
2. Crystal, R. G., P. B. Bitterman, S. I. Ronnard, and B. A. Keogh. 1984. Interstitial lung disease of unknown cause: disorders characterized by chronic inflammation of the lower respiratory tract. N. Engl. J. Med. 310:154-156, 235-244.
3. Fels, A. O. S., C. F. Nathan, and Z. A. Cohn. 1987. Hydrogen peroxide release by alveolar macrophage from sarcoid patients and by alveolar macrophage from normals after exposure to recombinant interferon α, β, and γ and 1,25-dihydroxyvitamin D3. J. Clin. Invest. 80:381-386.
4. Strausz, J., J. Miiller-Quernheim, H. Steppling, and R. Ferlinz. 1990. Oxygen radical production by alveolar inflammatory cells in idiopathic pulmonary fibrosis. Am. Rev. Respir. Dis. 141:124-128.
5. Watters, L. C., M. I. Schwarz, R. M. Cherniack, J. A. Waldron, T. L. Dunn, R. E. Stanford, and T. E. King. 1987. Idiopathic pulmonary fibrosis: pretreatment bronchoalveolar lavage cellular constituents and their relationship with histopathology and clinical response to therapy. Am. Rev. Respir. Dis. 135:696-704.
6. The BAL Cooperative Group Steering Committee. 1990. Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups. Am. Rev. Respir. Dis. 141:S169-S201.
7. Schroeder, J. M., U. Mrowietz, E. Monta, and E. Christophers. 1987. Purification and partial biochemical characterization of a human monocyte-derived neutrophil-activating peptide that lacks interleukin-1 activity. J. Immunol. 139:3474-3483.
8. Car, B. D., F. Meloni, M. Luisetti, G. Semenzato, G. Gialdroni-Grassi, and A. Walz. 1994. Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am. J. Respir. Crit. Care Med. 149:655-659.
9. Southcott, A., A. Jones, S. Majumdar, A. Cambrey, C. Pantelidis, C. Black, G. Laurent, B. Davies, P. Jeffery, and R. duBois. 1995. Interleukin-8: differential expression in lone fibrosing alveolitis and systemic sclerosis. Am. J. Respir. Crit. Care Med. 151:1604-1612.
10. Carre, P. C., R. L. Mortenson, T. E. J. King, P. W. Noble, C. L. Sable, and D. W. H. Riches. 1991. Increased expression of the interleukin-8 gene by alveolar macrophages in idiopathic pulmonary fibrosis. J. Clin. Invest. 88:1802-1810.
11. Lynch, J. P., III, T. J. Standiford, M. W. Rolfe, S. L. Kunkel, and R. M. Stricter. 1992. Neutrophilic alveolitis in idiopathic pulmonary fibrosis: the role of interleukin-8. Am. Rev. Respir. Dis. 145:1433-1439.
12. Wells, A. U., P. Cullinan, D. M. Hansell, M. B. Rubens, C. M. Black, A. J. Newmann-Taylor, and R. M. du Bois. 1994. Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis. Am. Rev. Respir. Dis. 149:1583-1590.
13. Meier-Sydow, J., S. Weiss, R. Buhl, M. Rust, and G. Raghu. 1994. Idiopathic pulmonary fibrosis: current clinical concepts and challenges in management. Semin. Respir. Crit. Care Med. 15:77-96.
14. Müller, N. L., and R. R. Miller. 1990. Computed tomography of chronic diffuse infiltrative lung disease. Am. Rev. Respir. Dis. 142:1206-1215, 1440-1448.
15. Zabel, P., P. Entzian, K. Dahlhoff, and M. Schlaak. 1997. Pentoxifylline in treatment of sarcoidosis. Am. J. Respir. Crit. Care Med. 155:1665-1669.
16. American Thoracic Society. 1995. Standardization of spirometry-1994 update. Am. J. Respir. Crit. Care Med. 152:1107-1136.
17. American Thoracic Society. 1995. Single-breath carbon monoxide diffusing capacity (transfer factor): recommendations for a standard technique-1995 update. Am. J. Respir. Crit. Care Med. 152:2185-2198.
18. Hunninghake, G., J. Gadek, T. Lawley, and R. Crystal. 1981. Mechanisms of neutrophilic accumulation in the lungs of patients with idio-pathic pulmonary fibrosis. J. Clin. Invest. 68:259-269.
19. Schwartz, D., R. Helmers, J. R. Calvin, D. S. van Fossen, K. L. Frees, C. S. Dayton, L. F. Burmeister, and G. W. Hunninghake. 1994. Determinants of survival in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 149:450-454.
20. Nakamura, H., S. Fujishima, Y. Waki, T. Urano, K. Sayama, F. Sakamaki, T. Terashima, K. Soejima, S. Tasaka, A. Ishizaka, T. Kawashiro, and M. Kanazawa. 1995. Priming of alveolar macrophages for interleukin-8 production in patients with idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 152:1579-1586.
21. Kanazawa, H., N. Kurihara, T. Otsuka, T. Fujii, S. Tanaka, S. Kudoh, K. Hirata, and T. Takeda. 1996. Clinical significance of serum concentration of interleukin-8 in patients with bronchial asthma or chronic pulmonary emphysema. Respiration 63:236-240.
22. Takizawa, H., M. Satoh, H. Okazaki, G. Matsuzaki, N. Suzuki, A. Ishii, M. Suko, and H. Okudaira. 1997. Increased IL-6 and IL-8 in bronchoalveolar lavage fluids (BALF) from patients with sarcoidosis: correlation with the clinical parameters, Clin. Exp. Immunol. 107:175-181.
23. Rudd, R. M., P. L. Haslan, and M. Turner-Warwick. 1981. Cryptogenic fibrosing alveolitis. Am. Rev. Respir. Dis. 124:1-8.
24. Turner-Warwick, M., and P. M. Haslam. 1987. The value of serial bronchoalveolar lavages in assessing the clinical progress of patients with cryptogenic fibrosing alveolitis. Am. Rev. Respir. Dis. 135:26-34.
25. Wells, A. U., D. M. Hansell, M. B. Rubens, P. Cullinan, P. L. Haslam, R. Lawrence, C. M. Black, and R. M. du Bois. 1992. Indices of lung in-flammation predict disease severity in fibrosing alveolitis as assessed by HRCT (abstract). Am. Rev. Respir. Dis. 149:A191.
26. Kragsbjerg, P., I. Jones, T. Vikerfors, and H. Holmberg. 1995. Diagnostic value of blood cytokine concentrations in acute pneumonia. Thorax 50:1253-1257.
27. Chollet-Martin, S., P. Montravers, C. Gibert, C. Elbim, J. M. Desmonts, J. Y. Fagon, and M. A. Gougerot-Pocidalo. 1993. High levels of interleukin-8 in the blood and alveolar spaces of patients with pneumonia and adult respiratory distress syndrome. Infect. Immunol. 11:4553-4559.
28. Miller, E. J., A. B. Cohen, S. Nagao, D. Griffith, R. J. Maunder, J. P. Weiner-Kronish, M. Sticherling, E. Christophers, and M. A. Matthay. 1992. Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am. Rev. Respir. Dis. 146:427-432.
29. Matusiewicz, S. P., I. J. Williamson, P. J. Sime, P. H. Brown, P. R. Wenham, G. K. Crompton, and A. P. Greening. 1993. Plasma lactate dehydrogenase: a marker of disease activity in cryptogenic fibrosing alveolitis and extrinsic allergic alveolitis? Eur. Respir. J. 6:1282-1286.
30. Kondoh, Y., H. Taniguchi, Y. Kawabata, T. Yokoi, K. Suzuki, and K. Takagi. 1993. Acute exacerbation in idiopathic pulmonary fibrosis: analysis of clinical and pathological findings in three cases. Chest 103:1808-1812.